Stock ScreenerStock IdeasZen Ratings + Top AnalystsStocks With a Zen Rating of A + Top Analyst consensus of Strong Buy + Large Upside in Target Price: Dec 13, 2025The 2 best sources of winning stocks is the Zen Ratings and our analysis of Top Analysts from Wall Street. Now we have combined them together in a best of both worlds approach to find stocks with the best upside potential.
Stock ScreenerStock IdeasZen Ratings + Top Analysts
Zen Rating: A
Upside/Downside: Large Upside
Top Analysts Consensus: Strong Buy
| Ticker | Company | Zen Rating | Sentiment | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|---|
| ALNY | ALNYLAM PHARMACEUTICALS INC | A | C | $52.52B | 132,113,818 | 82.79% | 17.21% | Net Selling | Net Selling |
| ONC | BEONE MEDICINES LTD | A | A | $35.34B | 1,438,553,263 | 2.29% | 32.11% | Net Buying | Net Selling |
| NVT | NVENT ELECTRIC PLC | A | B | $16.41B | 161,359,550 | 90.40% | 9.60% | Net Selling | Net Buying |
| VTRS | VIATRIS INC | A | B | $13.42B | 1,151,769,872 | 81.80% | 18.20% | Net Selling | |
| JAZZ | JAZZ PHARMACEUTICALS PLC | A | C | $10.18B | 60,765,116 | 28.42% | 71.58% | Net Selling | Net Selling |
| SGHC | SUPER GROUP (SGHC) LTD | A | A | $5.79B | 505,728,590 | 15.36% | 0.00% | ||
| MLCO | MELCO RESORTS & ENTERTAINMENT LTD | A | B | $3.45B | 1,276,540,382 | 9.38% | 0.00% | ||
| MIRM | MIRUM PHARMACEUTICALS INC | A | B | $3.34B | 51,393,574 | 52.35% | 47.65% | Net Selling | Net Buying |
| FOLD | AMICUS THERAPEUTICS INC | A | A | $3.26B | 308,533,548 | 65.98% | 34.02% | Net Selling | Net Selling |
| SUPN | SUPERNUS PHARMACEUTICALS INC | A | B | $2.70B | 57,339,350 | 45.49% | 54.51% | Net Buying | Net Buying |
| SPNT | SIRIUSPOINT LTD | A | A | $2.62B | 116,814,640 | 64.36% | 35.64% | Net Selling | |
| HCI | HCI GROUP INC | A | A | $2.43B | 12,960,037 | 78.69% | 9.80% | Net Selling | |
| EXTR | EXTREME NETWORKS INC | A | B | $2.26B | 133,718,479 | 82.39% | 17.61% | Net Selling | Net Selling |
| FIVN | FIVE9 INC | A | B | $1.65B | 78,216,052 | 71.46% | 28.54% | Net Selling | Net Selling |
| BLBD | BLUE BIRD CORP | A | C | $1.60B | 31,714,959 | 67.95% | 32.05% | Net Selling | Net Selling |
| NUTX | NUTEX HEALTH INC | A | B | $1.31B | 7,071,916 | 0.14% | 99.86% | Net Selling | Net Buying |
| ANAB | ANAPTYSBIO INC | A | A | $1.24B | 27,688,470 | 42.69% | 57.31% | Net Buying | Net Selling |
| DFIN | DONNELLEY FINANCIAL SOLUTIONS INC | A | B | $1.22B | 26,537,083 | 75.68% | 24.32% | Net Selling | |
| CRTO | CRITEO SA | A | A | $1.07B | 52,549,158 | 84.84% | 11.64% | Net Selling | Net Buying |
| TBPH | THERAVANCE BIOPHARMA INC | A | B | $920.72M | 50,672,431 | 52.91% | 47.09% | Net Selling | Net Selling |
| UDMY | UDEMY INC | A | B | $768.48M | 146,376,765 | 56.95% | 43.05% | Net Selling | Net Selling |
| BWMN | BOWMAN CONSULTING GROUP LTD | A | B | $629.08M | 17,373,129 | 51.74% | 48.26% | Net Selling | Net Selling |
| ORGO | ORGANOGENESIS HOLDINGS INC | A | B | $611.72M | 126,912,142 | 6.93% | 93.07% | Net Selling | Net Selling |
| BWMX | BETTERWARE DE MEXICO SAPI DE CV | A | C | $525.79M | 37,316,546 | 13.00% | 0.00% | ||
| VREX | VAREX IMAGING CORP | A | B | $488.31M | 41,700,000 | 93.34% | 1.83% | Net Selling | Net Selling |
| LE | LANDS' END INC | A | B | $472.01M | 30,551,068 | 13.36% | 86.64% | Net Selling | Net Selling |
| OPRX | OPTIMIZERX CORP | A | B | $249.04M | 18,640,652 | 52.17% | 47.83% | Net Buying | Net Selling |
| ELMD | ELECTROMED INC | A | A | $248.97M | 8,340,538 | 31.32% | 68.68% | Net Selling | |
| CXDO | CREXENDO INC | A | A | $212.04M | 30,731,048 | 25.99% | 48.85% | Net Selling | Net Selling |
| INFU | INFUSYSTEM HOLDINGS INC | A | A | $187.91M | 20,336,183 | 25.27% | 74.73% | Net Selling | Net Selling |
Upgrade to Premium to View More
Use the proven Zen Ratings quant model to find stocks with high potential to beat the market. Stocks Zen-Rated "A" have beaten the market by +32.52% annually. Learn More
Already have access to Premium? Sign In
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.